Patenting Antibody and Cell Therapies – What to Do and What Not to Do

In Webinars

28 September, 2020

Click here to watch webinar.

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is a complex task, with constantly evolving case law and practice on both sides of the Atlantic. In this webinar, AWA’s experts focus on how to create, defend and litigate these patents in Europe and elsewhere.

 

 

You may also be interested in:

Bad news for WhatsApp as Norwegian Board of Appeal refuses to register logo

With a reported total of more than 500 million users globally, many of us will have used or at

Read more...

The Busines of IP – Understanding and Creating Value: Part 1 – Venture Capital

In this six-part series, Anders Isaksson explores some of the key factors and motivators for why companies small or

Read more...

Protecting Biological Drug Innovations

  Learn how to protect biological drug innovations during this webinar from Stockholm Science City (In Swedish). Ulrika Munter and Nora Spjuth share their experiences

Read more...

Mobile Sliding Menu